期刊文献+

乳腺癌超声表现与生物学指标的相关性及对临床治疗的指导意义 被引量:15

Relation between ultrasound and immune-histochemical findings of breast cancer
下载PDF
导出
摘要 目的 探讨乳腺癌超声的边缘毛刺和微钙化灶与生物学指标雌激素受体(ER)、孕激素受体(PR)、c-erbB-2、p53的相关性,为乳腺癌术前辅助治疗及预后判断提供依据.方法 对45例手术后病理确诊为乳腺癌且测定ER、PR、c-erbB-2、突变型p53表达水平的病例进行超声图像回顾性观察,分析超声征象与分子生物学指标的关系,探讨其相关性.结果 ER、PR在具有边缘毛刺征肿块中的阳性表达率明显高于无边缘毛刺征的肿块,差异有统计学意义[85.3%(29/34)比36.4% (4/11),P=0.005;85.3% (29/34)比45.4% (5/11),P=0.008];而c-erbB-2、p53在有边缘毛刺征肿块和无边缘毛刺征肿块中的阳性表达率差异无统计学意义[58.8% (20/34)比27.3% (3/11),P=0.141;58.8% (20/34)比18.2% (2/11),P=0.072].c-erbB-2、p53在有微钙化灶的肿块中阳性表达率明显高于无微钙化征的肿块,差异有统计学意义94.4% (17/18)比22.2%(6/27),P=0.005;88.9%(16/18)比22.2%(6/27),P=0.000];而ER、PR有微钙化灶的肿块中阳性表达率与无微钙化征的肿块差异无统计学意义[72.2% (13/18)比74.1%(20/27),P =0.953;83.3% (15/18)比70.4%(19/27),P=0.534].结论 乳腺癌超声表现的边缘毛刺征和微钙化征可以从一定程度上预测某些免疫组织化学因子(ER、PR、c-erbB-2,p53)的表达水平;可以根据乳腺癌的超声表现预测其生物学行为,在免疫组织化学因子检测结果出来前早期指导临床治疗. Objective To investigate the ultrasound burr on the edge of the breast cancer,tiny calcification and biological indicators such as estrogen receptor (ER),progesterone receptor (PR),c-erbB-2 and p53; to provide guidance for preoperative adjuvant therapy for breast cancer and prognosis judgments.Methods Totally 45 cases pathologically diagnosed of breast cancer after operation were enrolled; ER,PR,c-erbB-2 cases and p53 expression were detected ; the relation between the ultrasonic manifestations and molecular biological indicator were analyzed.Results Level of ER and PR was significantly higher in mass with edge burr of lump than that in mass without edge burr[85.3% (29/34) vs 36.4% (4/11),P =0.005 ; 85.3% (29/34) vs 45.4% (5/11),P =0.008] ; the positive rate of c-erbB-2 and p53 in mass with edge burr of lump and in mass without edge burr did not have statistically significant difference [58.8% (20/34) vs 27.3% (3/11),P =0.141 ; 58.8% (20/34) vs 18.2% (2/11),P =0.072].The level of c-erbB-2 and p53 was significantly higher in tumor with micro calcifications than that in tumor without micro calcifications [94.4% (17/18) vs 22.2% (6/27),P =0.005 ; 88.9% (16/18) vs 22.2% (6/27),P =0.000].The positive expression rate of ER and PR in tumors with and without micro calcifications had no statistically significant difference[72.2% (13/18) vs 74.1% (20/27),P =0.953; 83.3% (15/18)vs 70.4% (19/27),P =0.534].Conclusions Edge burr sign and micro calcification sign for breast cancer in ultrosound imaging can be used to predict the expression level of certain immunohistochemical factors (ER,PR,c-erbB-2,p53).The biologic behavior of breast cancer can be predicted according to the ultrasonographic features,which can provide guide for early clinical treatment.
出处 《中国医药》 2015年第1期1-4,共4页 China Medicine
关键词 乳腺癌 边缘毛刺征 微钙化征 Breast cancer Edge burr Microcalcification
  • 相关文献

参考文献29

  • 1DeSantis C, Siegel R, Bandi P, et al. Breast cancer statistics. 2011 [ J]. CA Cancer J Clin, 2011,61 (6) :409-418.
  • 2Fiets WE, Bellot FE, Struikmans H,et al. Prognostic value of mi- totic counts in axillary node negative breast cancer patients with predominantly well-differentiated tmnours[ J ]. Eur J Surg Oncol, 2005,31 (2) : 128-133.
  • 3陈晓耕,林志武,柳燕,林镇和.三阴性乳腺癌的临床病理特点及预后因素分析[J].福建医科大学学报,2009,43(2):172-174. 被引量:4
  • 4姜楠,颜承平,刘晋红,张宗明.乳腺癌组织中雌孕激素受体、c-erbB-2、p53、bcl-2及pS2的表达及意义[J].中华临床医师杂志(电子版),2010,4(11):48-51. 被引量:14
  • 5江泽飞,徐兵河,宋三泰,孙燕.乳腺癌内分泌治疗的基本共识[J].中华肿瘤杂志,2006,28(3):238-239. 被引量:48
  • 6Kasami M, Uematsu T, Honda M, et al. Comparison eft estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre-and post-neoadjuvant chemotherapy [ J ]. Breast, 2008,17 ( 5 ) : 523 -527.
  • 7Azizun-Nisa, Bhurgri Y, Raza F, et al. Comparison of ER, PR and HER-2/neu (C-erl) B 2) reactivity pattefn with histologic grade, tumor size and lymph node status in breast eancer[ J]. Asi- an Pac J Cancer Prey, 2008,9(4) :553-556.
  • 8Midulla C, De Iorio P, Nagar C, et ai. Immunohistochemical ex- pression of f)53, nna23-HI, Ki67 and DNA ploidy: correlation with lymph node status and other clinical pathologic parameters in breast caneer[ J ]. Anticancer Res, 1999,19(5B) :4033-4037.
  • 9Linjawi A, Kontogiannea M, Halwani F, et al. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer[J]. J Am Coil Surg, 2004,198( 1 ) :83-90.
  • 10黄宝俊,徐惠绵,李凯,王怀宇,张昊,田大彤.联合检测多基因在乳腺癌组织中的表达及其临床意义[J].中国普通外科杂志,2005,14(4):247-252. 被引量:11

二级参考文献165

共引文献240

同被引文献143

引证文献15

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部